Chart Scan – Apr 13, 2023
ABCL – AbCellera Biologics Inc.
ACET – Adicet Bio, Inc.
ALBT – Avalon GloboCare Corp.
ALLO – Allogene Therapeutics, Inc.
AMAM – Ambrx Biopharma Inc.
ARDX – Ardelyx, Inc.
AUTL – Autolus Therapeutics Plc
AUUD – Auddia Inc.
AVXL – Anavex Life Sciences Corp.
BBIG – Vinco Ventures, Inc.
CELL – PhenomeX Inc.
CXAI – CXApp Holding Corp.
EDIT – Editas Medicine, Inc.
FATE – Fate Therapeutics, Inc.
FLGC – Flora Growth Corp.
GERN – Geron Corp.
GOGL – Golden Ocean Group Limited
IBRX – ImmunityBio, Inc.
IMGN – ImmunoGen, Inc.
INO – Inovio Pharmaceuticals, Inc.
INPX – Inpixon
JZXN – Jiuzi Holdings Inc.
KPTI – Karyopharm Therapeutics Inc.
KRBP – Kiromic BioPharma Inc.
MDVL – MedAvail Holdings, Inc.
MGNI – Magnite, Inc
MNKD – MannKind Corp.
MRAI – Marpai Inc.
OCGN – Ocugen Inc.
OCUL – Ocular Therapeutix Inc.
PDSB – PDS Biotechnology Corporation
POAI – Predictive Oncology Inc.
RIGL – Rigel Pharmaceuticals Inc.
SABS – SAB Biotherapeutics Inc.
SDC – SmileDirectClub Inc.
SEER – Seer Inc.
TDUP – ThredUp Inc.
VBLT – Vascular Biogenics Ltd.
VERU – Veru Inc.
VNDA – Vanda Pharmaceuticals Inc.
Disclaimer:
We have not received any form of compensation for the generation of this blog
Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.
Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.
We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.